Mirae Asset Global Investments Co., Ltd. Apellis Pharmaceuticals, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $20 Billion
- Q2 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 3,623 shares of APLS stock, worth $128,725. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,623
Previous 50,299
92.8%
Holding current value
$128,725
Previous $2.96 Million
95.33%
% of portfolio
0.0%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding APLS
# of Institutions
299Shares Held
113MCall Options Held
5.21MPut Options Held
691K-
Wellington Management Group LLP Boston, MA16.4MShares$582 Million0.11% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.6MShares$412 Million15.74% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$395 Million5.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.81MShares$349 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.8MShares$206 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $3.9B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...